Arimidex
Product Images NDC 54868-5000

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Arimidex (NDC 54868-5000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Arimidex 1mg (30 tablet count bottle label)

Arimidex 1mg (30 tablet count bottle label)
This appears to be a label or packaging information for a medication called "Arimider 1HG". The medication is distributed by a company called "Physicians Total Care". The label also includes a lot number, an expiration date of 01/60, and a code "NDC 54868-5060-0". The last line may be a serial or batch number "SH00E300600".*
FDA Label Image

Chemical Structure For Anastrozole (Arimidex Chem)

Chemical Structure For Anastrozole (Arimidex Chem)
FDA Label Image

Figure 5 (Arimidex Figurefive)

Figure 5 (Arimidex Figurefive)
FDA Label Image

Figure 1 (Arimidex Figureone 01)

Figure 1 (Arimidex Figureone 01)
FDA Label Image

Figure 6 (Arimidex Figuresix)

Figure 6 (Arimidex Figuresix)
FDA Label Image

Figure 3 (Arimidex Figurethree 01)

Figure 3 (Arimidex Figurethree 01)
FDA Label Image

Figure 2 (Arimidex Figuretwo 01)

Figure 2 (Arimidex Figuretwo 01)
This is a medical data table comparing the effectiveness of two treatments, "anastrozole" and "tamoxifen", for an unspecified disease. The table displays the proportion of patients who survived without disease progression for a certain number of months. The table also lists the number of patients who were still alive without disease progression during each month of the study. There are two columns labeled "ansstrozole" and "tamoxifen" with numbers representing the number of patients in each group. Unfortunately, there is not enough information to understand the specifics of the study or the disease being treated.*
FDA Label Image

Figure 4 (Arimidextablenumbercorrection Figfour)

Figure 4 (Arimidextablenumbercorrection Figfour)
The text appears to be a graph showing the proportion of event-free patients over time for randomized treatment with either Anastrozole or Tamoxifen. The number of patients at risk is shown at different time intervals from 0 to 120 months. The vertical axis has been truncated to improve the clarity of the Kaplan-Meier curves.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.